Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. (SHA:603392)

Market Cap	43.52B -47.5%
Revenue (ttm)	1.94B +2.5%
Net Income	-388.47M
EPS	-0.30
Shares Out	1.26B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	4,505,236
Open	35.01
Previous Close	35.36
Day's Range	34.14 - 35.35
52-Week Range	34.14 - 80.00
Beta	0.78
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 21, 2026

About SHA:603392

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening. It also provides di...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1991
• Employees: 4,116
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603392